Delivery Order SPE2DB22D3301-SPE2DB25FX8XT
Award Date
1/23/25
Potential Completion Date
1/24/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $29,733.79 and a completion date of June 6, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM6B1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a medication, with a ceiling value of $2,793.30. It is a Firm Fixed Price delivery order contract with a completion date of February 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $12,594.72, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of June 24, 2024. The contract is for the procurement of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF2N5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $6,291.50 Firm Fixed Price Delivery Order is for the supply of 4563370662 ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, with ID SPE2DB22D2211|SPE2DB25FRVMH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567957073 - ELIQUIS 5 MG TABLET 60S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,693.72 and an ultimate completion date of April 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, SPE2DB20D2002|SPE2DB25FL20H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, with a ceiling value of $11,969.79 and a completion date of February 18, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $7,834.46 and is a firm fixed-price delivery order with a completion date of November 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,115.92, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 13, 2025. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY9PU, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,969.60 and a period of performance through July 1, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside designation was used for...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FE9ZD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $8,952.43. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure, and an ultimate completion date of November 27, 2024. This award is not...